Aehr Reports Record Revenue and Profit for Fiscal 2023 and Guides for Over 50% Increase in Revenue for Fiscal 2024 on Strength from Semiconductor Wafer Level Test and Burn-in Demand
- Aehr Test Systems achieved record net sales of $22.3 million in Q4 and $65.0 million for fiscal year 2023, representing a 28% and 28% increase, respectively, compared to the previous year. The company also reported a record GAAP net income of $6.1 million in Q4 and $14.6 million for the fiscal year, up 5% and 54%, respectively. Backlog as of May 31, 2023, was $24.5 million, indicating strong demand for the company's products. Aehr Test Systems expects total revenue for fiscal year 2024 to be at least $100 million, representing a growth of over 50% year over year. The company also projects a GAAP net income of at least $28 million, indicating strong profitability.
- None.
FREMONT, Calif., July 13, 2023 (GLOBE NEWSWIRE) -- Aehr Test Systems (NASDAQ: AEHR), a worldwide supplier of semiconductor test and production burn-in equipment, today announced financial results for its fiscal 2023 fourth quarter and full year ended May 31, 2023.
Fiscal Fourth Quarter Financial Results:
- Net sales were a record
$22.3 million , up from$20.3 million in the fourth quarter of fiscal 2022. - GAAP net income was a record
$6.1 million , or$0.21 per diluted share, up from GAAP net income of$5.8 million , or$0.20 per diluted share, in the fourth quarter of fiscal 2022. - Non-GAAP net income, which excludes the impact of stock-based compensation, was a record
$6.8 million , or$0.23 per diluted share, compared to non-GAAP net income of$6.5 million , or$0.23 per diluted share, in the fourth quarter of fiscal 2022. - Backlog as of May 31, 2023, was
$24.5 million . Effective backlog, which includes all orders received since the end of the fourth quarter, is$39.7 million . - Total cash, cash equivalents, and short-term investments as of May 31, 2023 were
$47.9 million , up from$31.5 million at May 31, 2022.
Fiscal Year Financial Results:
- Net sales were a record
$65.0 million , up28% from$50.8 million in fiscal 2022. - GAAP net income was a record
$14.6 million , or$0.50 per diluted share, up54% from GAAP net income of$9.5 million , or$0.34 per diluted share, in fiscal 2022. - Non-GAAP net income, which excludes the impact of stock-based compensation, was a record
$17.3 million , or$0.59 per diluted share, up62% from non-GAAP net income of$10.7 million , or$0.38 per diluted share, in fiscal 2022.
An explanation of the use of non-GAAP financial measures and a reconciliation of Aehr’s non-GAAP financial measures to the most directly comparable GAAP financial measures can be found in the accompanying tables.
Gayn Erickson, President and CEO of Aehr Test Systems, commented:
“We are pleased to report record financial performance for both the quarter as well as the entire fiscal year ended May 31. For fiscal 2023, total revenue grew
“We saw fiscal 2023 as a breakout year for our unique and proprietary wafer level test and burn-in products. These products provide complete solutions for semiconductor manufacturers for high-volume test, burn-in, and stabilization of semiconductors such as those used in electric vehicles, electric vehicle charging infrastructure, photovoltaic (solar) power conversion, and data and telecommunications infrastructure. We also see on the horizon a significant new market opportunity for test and burn-in of semiconductors such as silicon photonics devices used in optical input/output (I/O) and co-packaged optics for data farms, computing, and Artificial Intelligence (AI) markets.
“In our fiscal fourth quarter just completed, we received the first purchase order from another new silicon carbide semiconductor company for our production FOX-XP solution to be used for volume production wafer level test and burn-in of silicon carbide devices for electric vehicles, trucks, and train traction inverter modules. The train traction inverter application represents an exciting new market driver for our FOX production test solutions due to the extreme reliability and length of service requirements of this application leading to prolonged test times. This new customer, a multinational industrial conglomerate and manufacturer of semiconductors including power semiconductors, is forecasting to grow their silicon carbide business significantly to meet the market demand, which we forecast will in turn drive incremental capacity of our FOX systems as well as our proprietary WaferPak full wafer Contactors.
“With the addition of this latest customer, we have significantly expanded our customer base by adding a total of four new silicon carbide customers this year. Each of these customers is already ramping or plans to ramp our products into high-volume production using our multi wafer test and burn-in systems.
“We also have multiple potential customers inquiring about our systems with the new high voltage option introduced last year to test and burn-in gallium nitride (GaN) semiconductors for power conversion applications. The gallium nitride market appears to be a potentially significant growth driver for our systems and WaferPak full wafer Contactors, particularly for automotive and photovoltaic applications where burn-in appears to be critical for meeting the initial quality and reliability needs of those markets.
“We also see a major market opportunity with the upcoming application of silicon photonics integrated circuits for use in optical chip-to-chip communication. This is in addition to the current photonics transceiver market used in data and telecommunications. Multiple companies such as Intel, nVidia, AMD, TSMC, and Global Foundries have made announcements regarding their product roadmaps for co-packaged photonics integrated circuits with microprocessors, graphics processors, chip sets for computing as well as artificial intelligence applications. During the fiscal fourth quarter, we received our first order from a current major silicon photonics customer for a volume production FOX-XP configured to enable cost-effective production test of wafers of next-generation photonic integrated circuits, which can be used in new optical I/O or heterogeneous integrated packages. This customer is one of the world’s largest semiconductor manufacturers and we expect to receive orders for additional production systems as they increase production of these devices.
“Another major milestone is that we have now installed both configurations of our new fully automated WaferPak Aligner at multiple customers, with the standalone Aligner already accepted and released into production just this week, and the FOX-XP with integrated Aligner expected to receive acceptance before the end of our current fiscal first quarter. Our new automated WaferPak Aligner allows hands free operation of WaferPak handling and Alignment and is available either as a standalone with movement between the Aligner and portable carts or in full integration with the FOX-XP system. As capacity and volume forecast increase, eliminating all manual interfaces for automated handling can become critical. The added automation capability of our new Aligner gives our wafer level test and burn-in offering even greater value and opens several incremental markets to Aehr, such as high-volume processors and chipsets with integrated photonics transceivers, flash and ultimately DRAM memories. This capability is also important for high volume, high mix devices requiring extremely high reliability and
“The market forecast for wafer level burn-in products is significant. William Blair estimates that the total available market for wafer level burn-in products for silicon carbide alone will be over
“We start fiscal 2024 with an effective backlog of almost
Fiscal 2024 Financial Guidance:
For the fiscal year ending May 31, 2024, Aehr expects total revenue to be at least
Management Conference Call and Webcast
Aehr Test Systems will host a conference call and webcast today at 5:00 p.m. Eastern (2:00 p.m. PT) to discuss its fiscal 2023 fourth quarter and full year operating results. To access the live call, dial +1 844-735-3765 (US and Canada) or +1 412-317-5712 (International) and ask to join the Aehr Test Systems earnings call.
In addition, a live and archived webcast of the conference call will be available over the Internet at www.aehr.com in the Investor Relations section and may also be accessed by clicking here. A replay of the conference call will also be available via telephone beginning approximately two hours after conclusion of the call and will remain available for one week. To access the call replay, dial +1 877-344-7529 (US and Canada) or +1 412-317-0088 (International) and enter replay passcode 7898611.
About Aehr Test Systems
Headquartered in Fremont, California, Aehr Test Systems is a leading provider of test solutions for testing, burning-in, and stabilizing semiconductor devices in wafer level, singulated die, and package part form, and has installed thousands of systems worldwide. Increasing quality, reliability, safety, and security needs of semiconductors used across multiple applications, including electric vehicles, electric vehicle charging infrastructure, solar and wind power, computing, data and telecommunications infrastructure, and solid-state memory and storage, are driving additional test requirements, incremental capacity needs, and new opportunities for Aehr Test products and solutions. Aehr has developed and introduced several innovative products including the FOX-P™ families of test and burn-in systems and FOX WaferPak™ Aligner, FOX WaferPak Contactor, FOX DiePak® Carrier and FOX DiePak Loader. The FOX-XP and FOX-NP systems are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize a wide range of devices such as leading-edge silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets, and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices. The FOX-CP system is a low-cost single-wafer compact test solution for logic, memory and photonic devices and the newest addition to the FOX-P product family. The FOX WaferPak Contactor contains a unique full wafer contactor capable of testing wafers up to 300mm that enables IC manufacturers to perform test, burn-in, and stabilization of full wafers on the FOX-P systems. The FOX DiePak Carrier allows testing, burning in, and stabilization of singulated bare die and modules up to 1024 devices in parallel per DiePak on the FOX-NP and FOX-XP systems up to nine DiePaks at a time. For more information, please visit Aehr Test Systems’ website at www.aehr.com.
Safe Harbor Statement
This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements generally relate to future events or Aehr’s future financial or operating performance. In some cases, you can identify forward-looking statements because they contain words such as "may," "will," "should," "expects," "plans," "anticipates,” “going to,” "could," "intends," "target," "projects," "contemplates," "believes," "estimates," "predicts," "potential," “sees,” or "continue," or the negative of these words or other similar terms or expressions that concern Aehr’s expectations, strategy, priorities, plans, or intentions. Forward-looking statements in this press release include, but are not limited to, Aehr’s ability to generate bookings and revenue increases in the future; future requirements and orders of Aehr’s new and existing customers; bookings forecasted for proprietary WaferPak™ and DiePak consumables across multiple market segments; the temporary nature of customer pushouts; shipping timelines for products and follow-on capacity orders; the growth of Aehr’s systems and consumables, including as a percentage of total sales; financial guidance for fiscal 2024, including related to revenue and profitability, and expectations regarding fiscal 2024; Aehr’s ability to expand its number of customers using its FOX-P™ solutions; the ability to secure potential customer engagements; and expectations related to long-term demand for Aehr’s productions and the attractiveness of key markets. The forward-looking statements contained in this press release are also subject to other risks and uncertainties, including those more fully described in Aehr’s recent 10-K, 10-Q and other reports filed from time to time with the Securities and Exchange Commission. Aehr disclaims any obligation to update information contained in any forward-looking statement to reflect events or circumstances occurring after the date of this press release.
– Financial Tables to Follow –
AEHR TEST SYSTEMS AND SUBSIDIARIES | ||||||||||||||||||||
Condensed Consolidated Statements of Operations | ||||||||||||||||||||
(in thousands, except per share data) | ||||||||||||||||||||
(unaudited) | ||||||||||||||||||||
Three Months Ended | Year Ended | |||||||||||||||||||
May 31, | Feb 28, | May 31, | May 31, | May 31, | ||||||||||||||||
2023 | 2023 | 2022 | 2023 | 2022 | ||||||||||||||||
Net sales | $ | 22,269 | $ | 17,206 | $ | 20,289 | $ | 64,961 | $ | 50,829 | ||||||||||
Cost of sales | 10,790 | 8,331 | 9,821 | 32,215 | 27,164 | |||||||||||||||
Gross profit | 11,479 | 8,875 | 10,468 | 32,746 | 23,665 | |||||||||||||||
Operating expenses: | ||||||||||||||||||||
Selling, general and administrative | 3,587 | 3,250 | 2,993 | 12,237 | 10,047 | |||||||||||||||
Research and development | 2,253 | 1,832 | 1,655 | 7,134 | 5,818 | |||||||||||||||
Total operating expenses | 5,840 | 5,082 | 4,648 | 19,371 | 15,865 | |||||||||||||||
Income from operations | 5,639 | 3,793 | 5,820 | 13,375 | 7,800 | |||||||||||||||
Interest income, net | 487 | 374 | 22 | 1,245 | 13 | |||||||||||||||
Gain from forgiveness of PPP loan | - | - | - | - | 1,698 | |||||||||||||||
Other (expense) income, net | (4 | ) | (18 | ) | (38 | ) | (3 | ) | 30 | |||||||||||
Income before income tax expense | 6,122 | 4,149 | 5,804 | 14,617 | 9,541 | |||||||||||||||
Income tax expense | (11 | ) | (17 | ) | (10 | ) | (60 | ) | (91 | ) | ||||||||||
Net income | $ | 6,111 | $ | 4,132 | $ | 5,794 | $ | 14,557 | $ | 9,450 | ||||||||||
Earnings per share | ||||||||||||||||||||
Basic | $ | 0.21 | $ | 0.15 | $ | 0.21 | $ | 0.52 | $ | 0.36 | ||||||||||
Diluted | $ | 0.21 | $ | 0.14 | $ | 0.20 | $ | 0.50 | $ | 0.34 | ||||||||||
Shares used in per share calculations: | ||||||||||||||||||||
Basic | 28,425 | 27,893 | 27,003 | 27,785 | 26,014 | |||||||||||||||
Diluted | 29,572 | 29,373 | 28,568 | 29,215 | 27,774 |
AEHR TEST SYSTEMS AND SUBSIDIARIES | ||||||||||||||||||||
Reconciliation of GAAP and Non-GAAP Results | ||||||||||||||||||||
(in thousands, except per share data) | ||||||||||||||||||||
(unaudited) | ||||||||||||||||||||
Three Months Ended | Year Ended | |||||||||||||||||||
May 31, | Feb 28, | May 31, | May 31, | May 31, | ||||||||||||||||
2023 | 2023 | 2022 | 2023 | 2022 | ||||||||||||||||
GAAP net income | $ | 6,111 | $ | 4,132 | $ | 5,794 | $ | 14,557 | $ | 9,450 | ||||||||||
Stock-based compensation expense | 654 | 592 | 737 | 2,749 | 2,923 | |||||||||||||||
Gain from forgiveness of PPP loan | - | - | - | - | (1,698 | ) | ||||||||||||||
Non-GAAP net income | $ | 6,765 | $ | 4,724 | $ | 6,531 | $ | 17,306 | $ | 10,675 | ||||||||||
GAAP earnings per diluted share | $ | 0.21 | $ | 0.14 | $ | 0.20 | $ | 0.50 | $ | 0.34 | ||||||||||
Non-GAAP earnings per diluted share | $ | 0.23 | $ | 0.16 | $ | 0.23 | $ | 0.59 | $ | 0.38 | ||||||||||
Shares used in GAAP diluted shares calculation | 29,572 | 29,373 | 28,568 | 29,215 | 27,774 | |||||||||||||||
Shares used in non-GAAP diluted shares calculation | 29,572 | 29,373 | 28,568 | 29,215 | 27,774 | |||||||||||||||
Non-GAAP net income is a non-GAAP measure and should not be considered a replacement for GAAP results. Non-GAAP net income is a financial measure the Company uses to evaluate the underlying results and operating performance of the business. The limitation of this measure is that it excludes items that impact the Company's current period net income. This limitation is best addressed by using this measure in combination with net income (the most directly comparable GAAP financial measure). These measures are not in accordance with GAAP and may differ from non-GAAP methods of accounting and reporting used by other companies. We believe these measures enhance investors’ ability to review the company’s business from the same perspective as the Company’s management and facilitate comparisons of this period’s results with prior periods. |
AEHR TEST SYSTEMS AND SUBSIDIARIES | ||||||||||||
Condensed Consolidated Balance Sheets | ||||||||||||
(in thousands, except per share data) | ||||||||||||
(unaudited) | ||||||||||||
May 31, | February 28, | May 31, | ||||||||||
2023 | 2023 | 2022 | ||||||||||
ASSETS | ||||||||||||
Current assets: | ||||||||||||
Cash and cash equivalents | $ | 30,054 | $ | 17,188 | $ | 31,484 | ||||||
Short-term investments | 17,853 | 25,577 | - | |||||||||
Trade and other accounts receivable, net | 16,594 | 11,389 | 12,859 | |||||||||
Inventories | 23,908 | 21,619 | 15,051 | |||||||||
Prepaid expenses and other | 621 | 808 | 613 | |||||||||
Total current assets | 89,030 | 76,581 | 60,007 | |||||||||
Property and equipment, net | 2,759 | 1,281 | 1,203 | |||||||||
Operating lease right-of-use assets | 6,123 | 6,293 | 917 | |||||||||
Other assets | 231 | 241 | 201 | |||||||||
Total assets | $ | 98,143 | $ | 84,396 | $ | 62,328 | ||||||
LIABILITIES AND SHAREHOLDERS' EQUITY | ||||||||||||
Current liabilities: | ||||||||||||
Accounts payable | $ | 9,206 | $ | 4,988 | $ | 4,195 | ||||||
Accrued expenses | 4,143 | 3,489 | 3,610 | |||||||||
Operating lease liabilities, short-term | 137 | 68 | 794 | |||||||||
Customer deposits and deferred revenue, short-term | 2,822 | 843 | 2,415 | |||||||||
Total current liabilities | 16,308 | 9,388 | 11,014 | |||||||||
Operating lease liabilities, long-term | 6,163 | 6,324 | 212 | |||||||||
Deferred revenue, long-term | 31 | 8 | 69 | |||||||||
Other liabilities | 41 | 42 | 44 | |||||||||
Total liabilities | 22,543 | 15,762 | 11,339 | |||||||||
Total shareholders' equity | 75,600 | 68,634 | 50,989 | |||||||||
Total liabilities and shareholders' equity | $ | 98,143 | $ | 84,396 | $ | 62,328 |
Contacts: Aehr Test Systems Chris Siu Chief Financial Officer csiu@aehr.com | MKR Investor Relations Inc. Todd Kehrli or Jim Byers Analyst/Investor Contact (323) 468-2300 aehr@mkr-group.com |
FAQ
What were Aehr Test Systems' net sales for fiscal year 2023?
What is Aehr Test Systems' financial guidance for fiscal year 2024?
What was Aehr Test Systems' backlog as of May 31, 2023?
What was Aehr Test Systems' GAAP net income for Q4 of fiscal year 2023?